Emerging Startup in Traumatic Brain Injury (TBI)

BOSTON - Sept. 17, 2020 - PRLog -- Charleston, SC | Boston, MA: Power of Patients, LLC is an emerging healthcare-technology company that is redesigning the way people with TBIs and their caregivers manage this life-long condition. Power of Patients' mission is to empower TBI patients by offering them a free, customized symptom and trigger tracking dashboard while learning about new clinical trial therapies that may improve their lives. Because so little clinical trial research has been done on TBIs, CEO and Founder Lynne Becker has made it her goal to increase awareness and advocate for clinical trial research initiatives for traumatic brain injuries.

"I have learned through my 2 daughters' distinctively different head injuries, concussions versus TBI, that if you have seen 1 brain injury, then you have only experienced 1 brain injury.

No 2 brain injuries are alike," says Lynne Becker, CEO / Founder at Power of Patients.

Features and benefits of the Power of Patients' dashboard include.

●       Free, personalized customized symptom and trigger tracking system for patients and caregivers to manage their TBI

●       Options to share your real-time data with your provider

●       Educate users about clinical trials and how they can participate

The user dashboard is NOW LIVE and to celebrate this we are kicking off a fundraising and awareness campaign - https://www.gofundme.com/f/take-2 - concurring with National Concussion Day on September 18. The dashboard is free for users and people can learn more here: https://powerofpatients.com/

Background: The founder has worked in the clinical trial industry for over 20 years. When the founder became a fulltime caregiver for her own daughters, she discovered how severe the knowledge gap is among the health care providers as well as lack of clinical trials. Drawing upon her expertise in corporate, academic and government research, Power of Patients is developing a TBI ecosystem that serves patients, clinicians, and the clinical trial research industry.